REG - CVS Group plc - Transaction in Own Shares

CVSAnnouncement

02/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260102:nRSB3580Na&default-theme=true

RNS Number : 3580N  CVS Group plc  02 January 2026

02 January 2026

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 31 December 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").

 

 Date of purchase:                                    31/12/2025
 Aggregate number of Ordinary Shares purchased:       4,554
 Lowest price paid per share (GBp):                   1,266.00
 Highest price paid per share (GBp):                  1,278.00
 Volume weighted average price paid per share (GBp):  1,273.59

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 70,706,719 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,706,719 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has
repurchased 1,034,064 Ordinary Shares in aggregate at a weighted average price
of 1,221.27 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.

 

Individual transactions:

 

 Number of Ordinary Shares purchased  Transaction price (GBp share)  Time of transaction (UK Time)  Transaction reference number  Trading Venue

 70                                   1266                           31/12/2025 10:08:21            1361977762912325              XLON
 44                                   1266                           31/12/2025 10:26:31            1361977762912807              XLON
 1                                    1266                           31/12/2025 10:26:31            1361977762912808              XLON
 10                                   1266                           31/12/2025 10:26:31            1361977762912809              XLON
 6                                    1266                           31/12/2025 10:26:31            1361977762912810              XLON
 19                                   1266                           31/12/2025 10:26:31            1361977762912811              XLON
 6                                    1266                           31/12/2025 10:26:32            1361977762912812              XLON
 281                                  1268                           31/12/2025 10:39:29            1361977762913259              XLON
 25                                   1266                           31/12/2025 10:39:29            1361977762913260              XLON
 106                                  1268                           31/12/2025 10:39:29            1361977762913261              XLON
 111                                  1266                           31/12/2025 10:39:32            1361977762913262              XLON
 32                                   1268                           31/12/2025 10:50:04            1361977762913570              XLON
 9                                    1268                           31/12/2025 10:50:04            1361977762913571              XLON
 11                                   1268                           31/12/2025 10:50:04            1361977762913572              XLON
 276                                  1272                           31/12/2025 10:59:24            1361977762913854              XLON
 96                                   1272                           31/12/2025 10:59:24            1361977762913857              XLON
 85                                   1268                           31/12/2025 11:14:47            1361977762914340              XLON
 204                                  1276                           31/12/2025 11:23:24            1361977762914655              XLON
 191                                  1274                           31/12/2025 11:24:40            1361977762914690              XLON
 40                                   1276                           31/12/2025 11:29:31            1361977762914855              XLON
 115                                  1276                           31/12/2025 11:29:31            1361977762914856              XLON
 483                                  1270                           31/12/2025 11:43:40            1361977762915573              XLON
 553                                  1276                           31/12/2025 11:50:04            1361977762915810              XLON
 560                                  1276                           31/12/2025 11:50:04            1361977762915813              XLON
 78                                   1276                           31/12/2025 11:56:01            1361977762916089              XLON
 154                                  1276                           31/12/2025 12:01:30            1361977762916311              XLON
 231                                  1276                           31/12/2025 12:03:15            1361977762916359              XLON
 135                                  1276                           31/12/2025 12:03:15            1361977762916360              XLON
 178                                  1276                           31/12/2025 12:05:10            1361977762916425              XLON
 158                                  1278                           31/12/2025 12:11:22            1361977762916728              XLON
 286                                  1278                           31/12/2025 12:15:34            1361977762916940              XLON

 

 

Contacts

CVS Group
plc
via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint
Broker)
                    +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint
Broker)
                +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)
 
                                   cvsg@camarco.co.uk

Ginny
Pulbrook
+44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia.  CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSWPGGUPUPAGCG



            Copyright 2019 Regulatory News Service, all rights reserved